Our Leadership Team
Teri Sirset, MS
Founder, President & CEO
Teri Sirset is the Co-founder & CEO of DASI Simulations, a medical technology start-up located in Columbus Ohio. Teri has a passion for improving patient outcomes, born out of her father’s very difficult journey as he struggled with heart disease. Through the implementation of the DASI Simulations technology, Teri has found a way to work with physicians and dramatically raise their level of risk awareness and increase the level of safety associated with their very complex cardiac procedures. All of this is accomplished through the breakthrough application of Artificial Intelligence and Computational Modeling technologies. Teri is a high-level sales executive with 25+ years senior management experience in Medical Device Sales and Marketing. Prior to DASI Simulations, she was Vice President of Sales and New Business Development for a start-up company in the cardiovascular and neurovascular space, including a successful exit. Teri received her B.S. and M.S. from Ohio University while participating in an Entrepreneurship Accelerated Program at the Wharton School of Business.
Lakshmi Dasi, Ph.D.
Founder & CTO
Invented the technology for DASI Simulations and co-founded the company with Teri Sirset in 2019. Dr. Dasi is a leading bioengineer in the field of heart valve engineering with over 16 years of experience with an active and extensive publication record. Previously at The Ohio State University, he is currently running an independent research laboratory at the Georgia Institute of Technology as a Professor of Biomedical Engineering. Dr. Dasi has raised over $6M in federal funding towards heart valve research.
Sean McKibben, MBA, CPA
Kent Smith, MS
Kent is a successful medical surgical executive with several successful start-up medical device ventures including Suros Surgical (sold to Hologic, Inc), Cytomedix, Inc. (listed on AMEX exchange), Corvida Medical Fresenius, Inc pending) among others.
VP of Finance
Reed McCalmon – Serving as DASI’s VP of Finance, Reed has over 15 years of extensive startup finance and accounting experience. Assisting from idea phase through Series A, Reed has implemented financial practices that ensure Company’s success during growth stages. He has served as Director and CFO for Biotech companies such as Abreos Biosciences – focused on therapeutic drug monitoring of biologic therapies in the autoimmune, oncology, and neurology spaces, and Pareto Bio – a microbiome technology aiming to treat and prevent food allergies.